TD Cowen analyst Steve Scala maintained a Buy rating on AstraZeneca (AZN – Research Report) today. The company’s shares closed yesterday at ...
Sees FY25 revenue up high single-digit percentage. Sees FY25 tax rate 18%-22%. The company said, “The Company is unable to provide guidance on ...
Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.
AstraZeneca on Thursday said it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, raising investor hopes that the impact of several probes in the country could be ...
Univar Solutions LLC ("Univar Solutions" or "the Company") announced it has acquired UK-based Brad-Chem Holdings ("Brad-Chem") and its affiliated entities, which includes the acquisition of Brad-Kem, ...